Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1720851847;51848;51849 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
N2AB1556746924;46925;46926 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
N2A1464044143;44144;44145 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
N2B814324652;24653;24654 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
Novex-1826825027;25028;25029 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
Novex-2833525228;25229;25230 chr2:178609801;178609800;178609799chr2:179474528;179474527;179474526
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Fn3-13
  • Domain position: 62
  • Structural Position: 92
  • Q(SASA): 0.4287
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I None None 0.997 N 0.745 0.475 0.486920840936 gnomAD-4.0.0 2.73798E-06 None None None None N None 0 0 None 0 0 None 0 0 3.59932E-06 0 0
T/R None None 0.997 D 0.747 0.371 0.538097488659 gnomAD-4.0.0 6.84495E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99829E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1392 likely_benign 0.1423 benign -0.707 Destabilizing 0.977 D 0.431 neutral N 0.484960951 None None N
T/C 0.5077 ambiguous 0.497 ambiguous -0.42 Destabilizing 1.0 D 0.718 prob.delet. None None None None N
T/D 0.6406 likely_pathogenic 0.6142 pathogenic 0.044 Stabilizing 0.998 D 0.687 prob.neutral None None None None N
T/E 0.3699 ambiguous 0.3343 benign 0.021 Stabilizing 0.995 D 0.705 prob.neutral None None None None N
T/F 0.4342 ambiguous 0.4089 ambiguous -0.896 Destabilizing 0.999 D 0.781 deleterious None None None None N
T/G 0.5354 ambiguous 0.5258 ambiguous -0.931 Destabilizing 0.995 D 0.711 prob.delet. None None None None N
T/H 0.3239 likely_benign 0.3088 benign -1.204 Destabilizing 1.0 D 0.774 deleterious None None None None N
T/I 0.1845 likely_benign 0.1811 benign -0.214 Destabilizing 0.997 D 0.745 deleterious N 0.484289388 None None N
T/K 0.2267 likely_benign 0.2054 benign -0.649 Destabilizing 0.993 D 0.7 prob.neutral N 0.503285637 None None N
T/L 0.159 likely_benign 0.1592 benign -0.214 Destabilizing 0.983 D 0.61 neutral None None None None N
T/M 0.1218 likely_benign 0.1157 benign -0.01 Destabilizing 1.0 D 0.722 prob.delet. None None None None N
T/N 0.232 likely_benign 0.239 benign -0.524 Destabilizing 0.998 D 0.597 neutral None None None None N
T/P 0.2491 likely_benign 0.2921 benign -0.346 Destabilizing 0.117 N 0.367 neutral N 0.485974909 None None N
T/Q 0.2415 likely_benign 0.2268 benign -0.682 Destabilizing 0.998 D 0.756 deleterious None None None None N
T/R 0.2045 likely_benign 0.182 benign -0.409 Destabilizing 0.997 D 0.747 deleterious D 0.526605214 None None N
T/S 0.1825 likely_benign 0.1877 benign -0.792 Destabilizing 0.977 D 0.405 neutral N 0.483137299 None None N
T/V 0.1278 likely_benign 0.1246 benign -0.346 Destabilizing 0.991 D 0.487 neutral None None None None N
T/W 0.757 likely_pathogenic 0.7232 pathogenic -0.85 Destabilizing 1.0 D 0.771 deleterious None None None None N
T/Y 0.4441 ambiguous 0.4111 ambiguous -0.613 Destabilizing 0.999 D 0.781 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.